Search Results - "Goodkin, Donald E."

Comparative Outcomes for Individual Cognitive-Behavior Therapy, Supportive-Expressive Group Psychotherapy, and Sertraline for the Treatment of Depression in Multiple Sclerosis by Mohr, David C, Boudewyn, Arne C, Goodkin, Donald E, Bostrom, Alan, Epstein, Lucy

“…This study compared the efficacy of 3 16-week treatments for depression in 63 patients with multiple sclerosis (MS) and major depressive disorder (MDD):…”
Get full text

The Psychosocial Impact of Multiple Sclerosis: Exploring the Patient's Perspective by Mohr, David C, Dick, Leah P, Russo, David, Pinn, Jodi, Boudewyn, Arne C, Likosky, William, Goodkin, Donald E

“…This study examined subjective patient experiences of the psychosocial consequences of multiple sclerosis (MS). Fifty patients were interviewed regarding the…”
Get full text

Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis by Fischer, Jill S., Priore, Roger L., Jacobs, Lawrence D., Cookfair, Diane L., Rudick, Richard A., Herndon, Robert M., Richert, John R., Salazar, Andres M., Goodkin, Donald E., Granger, Carl V., Simon, Jack H., Grafman, Jordan H., Lezak, Muriel D., O'Reilly Hovey, Kathleen M., Kawczak Perkins, Katherine, Barilla-Clark, Danielle, Schacter, Mark, Shucard, David W., Davidson, Anna L., Wende, Karl E., Bourdette, Dennis N., Kooijmans-Coutinho, Mariska F.

“…Cognitive dysfunction is common in multiple sclerosis (MS), yet few studies have examined effects of treatment on neuropsychological (NP) performance. To…”
Get full text

Telephone-Administered Cognitive-Behavioral Therapy for the Treatment of Depressive Symptoms in Multiple Sclerosis by Mohr, David C, Likosky, William, Bertagnolli, Andrew, Goodkin, Donald E, Van Der Wende, Judy, Dwyer, Pat, Dick, Leah P

“…This study examined the efficacy of an 8-week telephone-administered cognitive-behavioral therapy (CBT) for the treatment of depressive symptomatology in…”
Get full text

Treatment of Depression in Multiple Sclerosis: Review and Meta-analysis by Mohr, David C., Goodkin, Donald E.

“…The aim of this article is to review the results of outcome studies of the treatment of depression in patients with multiple sclerosis (MS) using…”
Get full text

Therapy-related leukemia in mitozantrone treated patients by Goodkin, Donald E

Get full text

A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-1b in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis by TOUCHETTE, Daniel R, DURGIN, Tracy L, WANKE, Lee A, GOODKIN, Donald E

“…Information on the cost utility of interferon beta-1b and mitoxantrone hydrochloride, 2 disease-modifying agents approved by the US Food and Drug…”
Get full text

Glucocorticosteroid therapy for multiple sclerosis: A critical review by Andersson, Peter-Brian, Goodkin, Donald E

“…Controversy remains as to the efficacy, route of administration and dose of glucocorticosteroid (GCS) in multiple sclerosis (MS) therapy. With the recent…”
Get full text

A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-lb in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis by Touchette, Daniel R., Durgin, Tracy L., Wanke, Lee A., Goodkin, Donald E.

“…Information on the cost utility of interferon beta-lb and mitoxantrone hydrochloride, 2 disease-modifying agents approved by the US Food and Drug…”
Get full text

Mitoxantrone as a potential therapy for primary progressive multiple sclerosis by Stüve, Olaf, Kita, Mariko, Pelletier, Daniel, Fox, Robert J, Stone, Jerome, Goodkin, Donald E, Zamvil, Scott S

“…Mitoxantrone (Novantrone®) was the first drug approved in western Europe and North A merica for treatment of secondary progressive multiple sclerosis (SPMS)…”
Get full text

Identification of Beck Depression Inventory items related to multiple sclerosis by MOHR, D. C, GOODKIN, D. E, LIKOSKY, W, BEUTLER, L, GATTO, N, LANGAN, M. K

“…The percentage contribution of each item on the Beck Depression Inventory (BDI) to the total BDI score was compared across patients with multiple sclerosis…”
Get full text

Access to semantic memory in Parkinson's disease and multiple sclerosis by Beatty, W W, Monson, N, Goodkin, D E

“…The capacity to access semantic memory and the efficiency of the memory search were studied in patients with Parkinson's disease (PD) or multiple sclerosis…”
Get more information

Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis by Mohr, David C, Goodkin, Donald E, Nelson, Sarah, Cox, Darcy, Weiner, Michael

“…Many patients with multiple sclerosis (MS) report that stress can trigger disease exacerbations. Considerable research has supported a relationship between…”
Get full text

Interferon beta treatment for multiple sclerosis: persisting questions by Goodkin, D E

“…Doctors Noseworthy and Summerfield have reviewed the results of placebo-controlled, double-masked, clinical trials of interferon beta-1b (IFNB-1b, Betaseron)…”
Get more information

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis by Mohr, David C, Goodkin, Donald E, Masuoka, Lorianne, Dick, Leah P, Russo, David, Eckhardt, Jannelle, Boudewyn, Arne C, Bedell, Lisa

“…The purpose of this study was to examine the relationship between patient management strategies employed by study personnel, and patient retention and…”
Get full text

MS clinical trial design for the future by Goodkin, D E

“…The Clinical Outcomes Task Force has been challenged to develop new easily administered composite outcomes that are more sensitive, highly reliable, properly…”
Get more information

Linkage and association analysis of chromosome 19q13 in multiple sclerosis by PERICAK-VANCE, Margaret A, RIMMLER, Jacqueline B, MARTIN, Eden R, HAINES, Jonathan L, GARCIA, Melissa E, OKSENBERG, Jorge R, BARCELLOS, Lisa F, LINCOLN, Robin, GOODKIN, Donald E, HAUSER, Stephen L

“…Multiple sclerosis (MS) is an autoimmune neurological disorder with a complex etiology. Sibling risk, twin, and adoption studies have demonstrated that genes…”
Get full text

Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and infection anxiety on adherence and ability to self-inject by Mohr, David C., Boudewyn, Arne C., Likosky, William, Levine, Ellen, Goodkin, Donald E.

“…The management of many chronic illnesses involves medications that must be injected on a frequent basis. With fewer support resources available, patients are…”
Get full text

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis by Mohr, D C, Goodkin, D E, Likosky, W, Gatto, N, Baumann, K A, Rudick, R A

“…To examine the relationship between patient-reported depression and adherence to therapy with interferon beta-1b (IFN beta-1b) and to test the hypothesis that…”
Get more information

Linkage analysis of candidate myelin genes in familial multiple sclerosis by Seboun, E, Oksenberg, J R, Rombos, A, Usuku, K, Goodkin, D E, Lincoln, R R, Wong, M, Pham-Dinh, D, Boesplug-Tanguy, O, Carsique, R, Fitoussi, R, Gartioux, C, Reyes, C, Ribierre, F, Faure, S, Fizames, C, Gyapay, G, Weissenbach, J, Dautigny, A, Rimmler, J B, Garcia, M E, Pericak-Vance, M A, Haines, J L, Hauser, S L

“…Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system. A complex genetic etiology is thought to underlie susceptibility…”
Get full text